Siemens Healthineers releases test kit for coronavirus COVID-19

Siemens Healthineers announced today the availability of its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease. Test kits are already being shipped within the European Union for research use only (RUO) to expedite availability while the company continues to pursue Emergency Use Assessment and Listing (EUAL) from the World Health Organization (WHO) for clinical use. In addition, Siemens Healthineers has begun discussions with the U.S. Food and Drug Administration (FDA) for release of the test under Emergency Use Authorization (EUA). Both applications are in progress. While the controlled roll-out of the assay for research use is continuing, Siemens Healthineers is simultaneously expanding its production capacity.

Siemens Healthineers releases test kit for coronavirus COVID-19
The SARS-CoV-2 virus, which is the cause of COVID-19 outbreak.

With this molecular diagnostic assay, we want to make a contribution to fight the current COVID-19 global pandemic by delivering fast and accurate SARS-CoV-2 testing. The Siemens Healthineers assay is designed to help researchers positively identify the virus in less than three hours so that healthcare professionals can proceed as quickly as possible with the necessary next steps on their patients’ triage paths.”

Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers

Many molecular assays detect the presence of viral ribonucleic acid (RNA), determining the presence of the targeted virus directly in the patient sample. In this way, molecular testing is effective early in the lifecycle of the virus and is thus efficient in urgent testing situations, such as global pandemics. After regulatory approval, the commercial roll-out of the assay is intended in the U.S. and Europe.

The FTD SARS-CoV-2 Assay has been optimized on the Biomerieux EasyMag Extraction System and the Applied Biosystems 7500 Real-time PCR Thermocycler and utilizes the same workflow, including PCR profile, as other FTD Respiratory Disease kits from Siemens Healthineers. It can be run in laboratories simultaneously with FTD Respiratory Pathogens 21, a molecular syndromic testing panel from Siemens Healthineers that identifies 21 different upper respiratory pathogens that can cause acute respiratory infections.

The FTD SARS-CoV-2 Assay was developed by Fast Track Diagnostics, a Siemens Healthineers Company, in Esch-sur-Alzette, Luxembourg. Fast Track Diagnostics was acquired by Siemens Healthineers at the end of 2017.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Siemens Healthineers Point of Care Diagnostics. (2020, May 05). Siemens Healthineers releases test kit for coronavirus COVID-19. News-Medical. Retrieved on September 18, 2020 from https://www.news-medical.net/news/20200406/Siemens-Healthineers-releases-test-kit-for-coronavirus-COVID-19.aspx.

  • MLA

    Siemens Healthineers Point of Care Diagnostics. "Siemens Healthineers releases test kit for coronavirus COVID-19". News-Medical. 18 September 2020. <https://www.news-medical.net/news/20200406/Siemens-Healthineers-releases-test-kit-for-coronavirus-COVID-19.aspx>.

  • Chicago

    Siemens Healthineers Point of Care Diagnostics. "Siemens Healthineers releases test kit for coronavirus COVID-19". News-Medical. https://www.news-medical.net/news/20200406/Siemens-Healthineers-releases-test-kit-for-coronavirus-COVID-19.aspx. (accessed September 18, 2020).

  • Harvard

    Siemens Healthineers Point of Care Diagnostics. 2020. Siemens Healthineers releases test kit for coronavirus COVID-19. News-Medical, viewed 18 September 2020, https://www.news-medical.net/news/20200406/Siemens-Healthineers-releases-test-kit-for-coronavirus-COVID-19.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic